2026 NPPES data Specialist NPI 1164416251 MD
Verify on CMS →

MARK GRIFFIN, MD

Specialist in LINCOLN, Nebraska. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 625 beneficiaries · Specialist avg: 1K
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$988.05
42 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK GRIFFIN, MD is a Specialist ([object Object]) practicing in LINCOLN, Nebraska with a Medicare Part D prescribing footprint of 2K claims across 625 beneficiaries — 20% brand-name prescribing . Their CMS MIPS Final Score of 100/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $988.05 across 42 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK GRIFFIN, MD reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 1,634 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MARK GRIFFIN, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 09/06/2005

NPI 1164416251

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

1,634 11% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Nebraska

How Specialist compares to other specialties among Nebraska providers

Nebraska providers

Specialist share within Nebraska

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Nebraska

Medicare quality performance — MIPS

MARK GRIFFIN, MD's 2023 MIPS final score plotted against the Specialist national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Specialist) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Specialist) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK GRIFFIN, MD is a Specialist provider practicing in LINCOLN, Nebraska, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1164416251. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK GRIFFIN, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 4545 R ST, LINCOLN, NE, 68503, with a listed phone of (402) 465-4545. NPI 1164416251 was issued on 09/06/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GRIFFIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,634 prescription claims written by this provider, covering 625 Medicare beneficiaries and totaling roughly $959K in drug spend, split 20% brand-name and 80% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4545 R ST
LINCOLN, NE 68503

Provider Details

NPI 1164416251
Specialty Specialist
Credentials MD
Gender Male
NPI Issued 09/06/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK GRIFFIN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GASTROENTEROLOGY SPECIALTIES PC
LINCOLN, NE

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK GRIFFIN, MD. Source: openpaymentsdata.cms.gov.

Total received

$988

Largest payer

AIMMUNE THERAPEUTICS, INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MARK GRIFFIN, MD — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 1,634 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,634
Total Claims
$959K
Total Drug Cost
625
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,461
Total Day Supply
60,129
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$881K
Generic Drug Cost
$78K
Antibiotic Claims
49

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
1.16
Gender Split
60% female / 40% male
Age Distribution
<65: 66, 65-74: 312, 75-84: 210, 85+: 37

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Omeprazole
313
Pantoprazole Sodium
243
Plenvu
Peg3350/Sod Sul/Nacl/Kcl/Asb/C
86
Famotidine
60
Colestipol Hcl
40
Atorvastatin Calcium
26
Balsalazide Disodium
26
Lansoprazole
25
Ondansetron Hcl
23
Diphenoxylate-Atropine
Diphenoxylate Hcl/Atropine
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How MARK GRIFFIN, MD fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

MARK GRIFFIN, MD's 1,634 claims are above the specialty average of 1,474.

Nearby Specialist Providers in Nebraska

Other clinicians with the same primary specialty enrolled in Nebraska, drawn from the same CMS NPPES roster as GRIFFIN.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK GRIFFIN, MD's specialty?
MARK GRIFFIN, MD specializes in Specialist and practices in LINCOLN, Nebraska. Credentials: MD.
How much does MARK GRIFFIN, MD prescribe under Medicare Part D?
In 2023, MARK GRIFFIN, MD wrote 1,634 Medicare Part D claims totaling $959K in drug costs for 625 beneficiaries.
What is MARK GRIFFIN, MD's Medicare quality score?
MARK GRIFFIN, MD has a CMS MIPS Final Score of 100/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK GRIFFIN, MD located?
MARK GRIFFIN, MD is located at 4545 R ST, LINCOLN, NE, 68503. Phone: (402) 465-4545.
What is MARK GRIFFIN, MD's NPI number?
MARK GRIFFIN, MD's National Provider Identifier (NPI) is 1164416251, issued on 09/06/2005.
Does MARK GRIFFIN, MD prescribe more brand-name or generic drugs?
MARK GRIFFIN, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $881K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does MARK GRIFFIN, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK GRIFFIN, MD's most frequently prescribed drugs include Omeprazole, Pantoprazole Sodium, Plenvu. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK GRIFFIN, MD accept Medicare?
MARK GRIFFIN, MD appears in CMS Medicare data with 1,634 Part D claims and 625 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK GRIFFIN, MD's credentials?
MARK GRIFFIN, MD's NPI is 1164416251 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology